Individual Stock News:
1. China Railway Construction (01186.HK): New contract value for 2025 is RMB 3,076.497 billion, a year-on-year increase of 1.3%.
2. Hongxin Construction & Development (09930.HK) issued a profit warning: Expected profit attributable to shareholders for 2025 to decrease by 70%-90% year-on-year.
3. Financial Street Securities (01476.HK) issued a profit alert: Expected profit attributable to shareholders for 2025 to increase to approximately RMB 327 million year-on-year.
4. Tigermed (03347.HK) issued a profit alert: Expected net profit attributable to shareholders for 2025 to be approximately RMB 830 million-1.23 billion, a year-on-year increase of 105%-204%.
5. Meet Noodles (02408.HK) issued a profit alert: Expected profit for 2025 to be approximately RMB 100 million-115 million, a year-on-year increase of approximately 64.7%-89.5%. 6. Hengrui Medicine (01276.HK): Its application for marketing authorization of a new indication for injectable camrelizumab combined with apatinib mesylate tablets has been accepted.
7. Dazhong Public Utilities (01635.HK) issued a profit warning: It expects net profit attributable to shareholders for 2025 to be RMB 350 million to RMB 500 million, representing a year-on-year increase of 50.12% to 114.46%.
8. Guoquan (02517.HK) issued a profit warning: It expects net profit for 2025 to be approximately RMB 443 million to RMB 463 million, representing a year-on-year increase of approximately 83.7% to 92.0%.
9. Sunny Optical Technology (02382.HK) issued a profit warning: It expects profit attributable to shareholders for the year to be approximately RMB 4.5886 billion to RMB 4.7235 billion, representing a year-on-year increase of 70.0% to 75.0%.
10. Rainbow New Energy (00438.HK) issued a profit warning: It expects a net loss attributable to shareholders of approximately RMB 542 million to RMB 592 million for 2025, representing an increase of approximately 44.15% to 57.45% year-on-year.
11. Chunli Medical (01858.HK) released its 2025 annual results forecast: It expects net profit attributable to shareholders of RMB 245 million to RMB 288 million, representing an increase of 96.01% to 130.41% year-on-year.
12. Biocytogen-B (02315.HK) released its 2025 annual results forecast: It expects net profit attributable to shareholders of RMB 162 million to RMB 182 million, representing an increase of 384.26% to 443.88% year-on-year.
13. Aluminum Corporation of China (02600.HK) announced: It plans to acquire a stake in Brazilian aluminum through a joint venture.
14. Montage Technology: Plans to issue over 65 million shares in its Hong Kong IPO, with a maximum price of HK$106.89.
15. Aichip Technology: Plans to issue over 104 million shares in its Hong Kong IPO, priced at HK$28.2.
